ICON & the International Consortium for Health Outcomes Measurement Unveil the World’s First Global Patient Outcomes Benchm...
27 Octobre 2017 - 11:07AM
Business Wire
ICON plc, (NASDAQ: ICLR) a global provider of drug development
solutions and services to the pharmaceutical, biotechnology and
medical device industries, and the International Consortium for
Health Outcomes Measurement (ICHOM), a non-profit organization with
the mission of driving value based health care, shared the findings
of a global patient outcomes benchmarking platform at this week’s
ICHOM’s annual conference in Washington DC. The platform aims to
catalyse physician driven learning and improvement of the outcomes
that matter most to patients.
ICON and ICHOM first partnered to advance value-based healthcare
through the launch of a global healthcare outcomes benchmarking
pilot program called GLOBE in March 2016.
The pioneering work of the GLOBE pilot program, through its
collaboration with a global network of participating sites who
provided de-identified data, has enabled the development of a
global platform for collecting, storing, aggregating, analysing and
visualising health outcomes data. In just under 18 months, ICON and
ICHOM have processed in excess of 200 data transfers, collected
data from 70 health care facilities and developed risk-adjustment
algorithms based on over 75,000 procedures. This work was done in
close collaboration with the provider organizations who have full
ownership of the data and the clinical leaders and patients in the
working groups who defined the datasets in the first place.
The platform will provide decision support tools and insights to
participating health care organizations for optimising and
improving patient outcomes, using ICHOM developed Standard Sets.
ICHOM Standard Sets provide a common language and approach to
measuring outcomes at the medical condition level – ICHOM currently
has Standard Sets for 21 conditions that cover approximately 47% of
the global disease burden.
Professor Ola Rolfson, Department of Orthopaedics, Institute of
Clinical Sciences Sahlgrenska Academy, University of Gothenburg,
Sweden, expressed: “The GLOBE pilot program brings good news. It is
possible to engage institutions globally in collecting ICHOM
standard set data. The results have helped understand variation and
factors determining outcomes. By continuous feedback and
re-measuring, the program will keep striving to improve outcomes by
benchmarking as a network.”
The platform has been developed using the widely accepted OMOP
framework to effectively benchmark outcomes across diverse health
care organizations. The Standard Set specific benchmarking
visualizations will be unveiled at ICHOM’s annual conference on the
25th and 26th of October 2017 and will be available via a provider
portal in Q1 2018.
Professor Mats Lundstrom, Department of Clinical Sciences,
Ophthalmology, Faculty of Medicine, Lund University, Sweden stated:
“The use of a patient reported outcomes measure in cataract surgery
is not yet an established best practice. However, collecting and
evaluating important patient-reported data is of paramount
importance in understanding the patient’s perspective of care.
ICHOM’s GLOBE pilot program brings informed perspectives that
cannot be overlooked in the journey toward improving value for the
patient.”
Christina Rångemark Åkerman, President of ICHOM, commented: “The
GLOBE benchmarking pilot is an exciting example of outcomes in
action. For the first time, outcomes data from multiple hospitals
around the globe are collected and compared. The insights will
provide great opportunities to drive improvements in patient care
via learning and sharing of best practices between hospitals.”
Dr. Steve Cutler, Chief Executive Officer, ICON plc, commented:
““Today’s launch marks a major milestone towards the realisation of
ICHOM’s and ICON’s shared vision of improving patient care. The
measurement and sharing of outcomes will ultimately improve the
clinical development process by enabling better protocols that will
lead to the development of treatments that will be of most benefit
to patients. We are proud to have brought our clinical and
technical expertise in health outcomes and real-world data to help
ICHOM create the first global healthcare outcomes benchmarking
platform.”
About ICHOM
The International Consortium for Health Outcomes Measurement
(ICHOM) was founded by Michael E. Porter, PhD, Bishop William
Lawrence University Professor at Harvard Business School, The
Boston Consulting Group and Professor Martin Ingvar, Karolinska
Institutet with the mission to unlock the potential of value-based
health care by defining global Standard Sets of outcome measures
that really matter to patients for the most relevant medical
conditions and by driving adoption and reporting of these measures
worldwide. In January 18 2017 ICHOM and the Organisation for
Economic Cooperation and Development (OECD) signed a Letter of
Intent to collaborate on the collection, analysis and publishing of
patient reported outcomes for international comparison. To date
ICHOM have published Standard Sets covering 47 percent of the
global disease burden.
Further information is available at www.ichom.org
About ICON plc
ICON plc is a global provider of drug development solutions and
services to the pharmaceutical, biotechnology and medical device
industries. The company specialises in the strategic development,
management and analysis of programs that support clinical
development - from compound selection to Phase I-IV clinical
studies. With headquarters in Dublin, Ireland, ICON currently,
operates from 97 locations in 38 countries and has approximately
13,100 employees.
Further information is available at www.iconplc.com/ICHOM
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171027005251/en/
ICON Media ContactDeena MistryWeber Shandwick+44 (0)207
067 0387DMistry@webershandwick.com
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024